======= SPHK1 ======= == Gene Information == * **Official Symbol**: SPHK1 * **Official Name**: sphingosine kinase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8877|8877]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NYA1|Q9NYA1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SPHK1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SPHK1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603730|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro- sphingosine and to a lesser extent sphinganine, but not other lipids, such as D,L-threo-dihydrosphingosine, N,N- dimethylsphingosine, diacylglycerol, ceramide, or phosphatidylinositol. {ECO:0000269|PubMed:20577214, ECO:0000269|PubMed:23602659}. |DAGK cat| |sphingoid catabolic process| |regulation of endosomal vesicle fusion| |sphinganine kinase activity| |D-erythro-sphingosine kinase activity| |negative regulation of sphingolipid biosynthetic process| |negative regulation of ceramide biosynthetic process| |sphingosine-1-phosphate receptor activity| |sphingosine-1-phosphate receptor signaling pathway| |sphingolipid mediated signaling pathway| |sphingosine biosynthetic process| |sphingoid biosynthetic process| |sphingosine metabolic process| |regulation of ceramide biosynthetic process| |regulation of membrane lipid metabolic process| |sphingoid metabolic process| |regulation of sphingolipid biosynthetic process| |NAD+ kinase activity| |regulation of microglial cell activation| |positive regulation of interleukin-17 production| |diol biosynthetic process| |acetyltransferase activity| |diol metabolic process| |positive regulation of p38MAPK cascade| |regulation of interleukin-17 production| |positive regulation of peptidyl-threonine phosphorylation| |regulation of vesicle fusion| |positive regulation of smooth muscle contraction| |regulation of neuroinflammatory response| |sphingolipid catabolic process| |protein phosphatase 2A binding| |membrane lipid catabolic process| |cellular response to vascular endothelial growth factor stimulus| |regulation of p38MAPK cascade| |regulation of peptidyl-threonine phosphorylation| |positive regulation of muscle contraction| |negative regulation of lipid biosynthetic process| |positive regulation of fibroblast proliferation| |regulation of macrophage activation| |positive regulation of mitotic nuclear division| |clathrin-coated pit| |regulation of tumor necrosis factor-mediated signaling pathway| |endocytic vesicle| |polyol biosynthetic process| |regulation of smooth muscle contraction| |lipid phosphorylation| |positive regulation of nuclear division| |cellular response to hydrogen peroxide| |positive regulation of NIK/NF-kappaB signaling| |regulation of fibroblast proliferation| |regulation of interleukin-1 beta production| |negative regulation of lipid metabolic process| |sphingolipid biosynthetic process| |regulation of interleukin-1 production| |presynapse| |regulation of phagocytosis| |regulation of NIK/NF-kappaB signaling| |DNA biosynthetic process| |polyol metabolic process| |alcohol biosynthetic process| |positive regulation of protein ubiquitination| |cellular response to antibiotic| |response to hydrogen peroxide| |membrane lipid biosynthetic process| |cellular response to reactive oxygen species| |positive regulation of protein modification by small protein conjugation or removal| |protein acetylation| |calcium-mediated signaling| |negative regulation of cellular amide metabolic process| |positive regulation of mitotic cell cycle| |positive regulation of NF-kappaB transcription factor activity| |early endosome membrane| |sphingolipid metabolic process| |lipid binding| |regulation of muscle contraction| |regulation of cytokine-mediated signaling pathway| |positive regulation of angiogenesis| |positive regulation of cell growth| |positive regulation of stress-activated MAPK cascade| |regulation of mitotic nuclear division| |positive regulation of stress-activated protein kinase signaling cascade| |regulation of response to cytokine stimulus| |positive regulation of vasculature development| |organic hydroxy compound biosynthetic process| |regulation of lipid biosynthetic process| |protein acylation| |regulation of nuclear division| |ammonium ion metabolic process| |response to reactive oxygen species| |cellular lipid catabolic process| |regulation of protein ubiquitination| |lipid modification| |calmodulin binding| |membrane lipid metabolic process| |regulation of endocytosis| |cellular response to toxic substance| |magnesium ion binding| |regulation of protein modification by small protein conjugation or removal| |protein folding| |regulation of stress-activated MAPK cascade| |regulation of muscle system process| |regulation of stress-activated protein kinase signaling cascade| |cellular response to oxidative stress| |positive regulation of growth| |positive regulation of DNA-binding transcription factor activity| |response to tumor necrosis factor| |positive regulation of cell cycle process| |regulation of angiogenesis| |lipid catabolic process| |response to antibiotic| |alcohol metabolic process| |regulation of vasculature development| |second-messenger-mediated signaling| |regulation of inflammatory response| |positive regulation of cell cycle| |response to oxidative stress| |regulation of lipid metabolic process| |cellular response to drug| |regulation of cellular amide metabolic process| |regulation of cell growth| |regulation of DNA-binding transcription factor activity| |positive regulation of cytokine production| |organic hydroxy compound metabolic process| |blood vessel development| |inflammatory response| |cellular response to growth factor stimulus| |positive regulation of cell migration| |response to toxic substance| |vasculature development| |cardiovascular system development| |positive regulation of cell motility| |response to growth factor| |response to inorganic substance| |positive regulation of cellular component movement| |positive regulation of MAPK cascade| |cell junction| |regulation of vesicle-mediated transport| |positive regulation of locomotion| |lipid biosynthetic process| |regulation of system process| |small molecule biosynthetic process| |regulation of leukocyte activation| |positive regulation of organelle organization| |regulation of mitotic cell cycle| |regulation of cell activation| |regulation of growth| |regulation of cytokine production| |regulation of cellular response to stress| |brain development| |DNA metabolic process| |regulation of cell cycle process| |regulation of MAPK cascade| |regulation of defense response| |head development| |regulation of cell migration| |circulatory system development| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |regulation of cell motility| |positive regulation of cell population proliferation| |cellular lipid metabolic process| |regulation of cellular component biogenesis| |central nervous system development| |regulation of locomotion| |negative regulation of cell death| |regulation of cellular component movement| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |response to drug| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |regulation of anatomical structure morphogenesis| |organonitrogen compound catabolic process| |regulation of response to external stimulus| |nucleobase-containing compound biosynthetic process| |response to cytokine| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |positive regulation of cellular component organization| |lipid metabolic process| |positive regulation of protein modification process| |phosphorylation| |regulation of organelle organization| |organic cyclic compound biosynthetic process| |G protein-coupled receptor signaling pathway| |defense response| |positive regulation of developmental process| |organonitrogen compound biosynthetic process| |regulation of protein phosphorylation| |DNA binding| |regulation of response to stress| |ATP binding| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |regulation of immune system process| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of multicellular organismal process| |small molecule metabolic process| |macromolecule biosynthetic process| |organic substance catabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11766 * **Expression level (log2 read counts)**: 0.77 {{:chemogenomics:nalm6 dist.png?nolink |}}